A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
FROM THE EDITOR-IN-CHIEF
The Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
Gregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
Project Facilitate offers assistance to medical professionals who want investigational drugs for their cancer patients.
by Richard Pazdur, MD
School counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her cancer diagnosis led her into patient advocacy.
by Marci A. Landsmann
Participants in Airbnb’s Open Homes program help nonprofit organizations to provide temporary lodging for cancer patients.
by Katherine Malmo
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
My most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis.
by Erin L. Boyle
A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.
by Cheryl Platzman Weinstock
Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.
by Jon Kelvey
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.
The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.
Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.
Follow My Lead
donate to the AACR